Intelligent Bio Solutions Inc. (INBS) stock
INBSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3057% below fair value
$1.56+0.06 (+4.00%)
Close on Nov 17, 2026Market cap $4.72MP/E –Yield –
Intelligent Bio Solutions operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Intelligent Bio Solutions's operating cash flow for the twelve months ending Jun 30, 2026 was -$11.93M. For fiscal 2026 it was -$11.93M. The highest annual figure on record is -$498.62K in fiscal 2020.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$11.93M | – |
| FY2025 | Jun 30, 2025 | -$9.68M | – |
| FY2024 | Jun 30, 2024 | -$9.57M | – |
| FY2023 | Jun 30, 2023 | -$7.38M | – |
| FY2022 | Jun 30, 2022 | -$3.36M | – |
| FY2021 | Jun 30, 2021 | -$11.30M | – |
| FY2020 | Jun 30, 2020 | -$498.62K | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$3.18M | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$4.33M | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$1.57M | – |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | -$2.85M | – |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$2.21M | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$2.76M | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | -$2.32M | – |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | -$2.39M | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$2.94M | – |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | -$2.45M | – |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | -$2.87M | – |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | -$1.31M | – |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | -$584.34K | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | -$2.52M | – |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | -$2.38M | – |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | -$1.89M | -2382.7% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$1.72M | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$292.22K | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -$1.43M | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $82.96K | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$1.68M | -963.1% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$6.16M | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$776.97K | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -$2.68M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $194.98K | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$218.65K | – |
See a number that looks wrong?